ATE139778T1 - Xanthinverbindungen - Google Patents
XanthinverbindungenInfo
- Publication number
- ATE139778T1 ATE139778T1 AT90116791T AT90116791T ATE139778T1 AT E139778 T1 ATE139778 T1 AT E139778T1 AT 90116791 T AT90116791 T AT 90116791T AT 90116791 T AT90116791 T AT 90116791T AT E139778 T1 ATE139778 T1 AT E139778T1
- Authority
- AT
- Austria
- Prior art keywords
- chem
- effect
- independently represents
- renal
- lower alkyl
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 230000001882 diuretic effect Effects 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000003182 bronchodilatating effect Effects 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/20—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22664289 | 1989-09-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE139778T1 true ATE139778T1 (de) | 1996-07-15 |
Family
ID=16848383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90116791T ATE139778T1 (de) | 1989-09-01 | 1990-08-31 | Xanthinverbindungen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0415456B1 (de) |
| JP (1) | JPH06102662B2 (de) |
| AT (1) | ATE139778T1 (de) |
| BR (1) | BR1100762A (de) |
| CA (1) | CA2024381C (de) |
| CY (1) | CY2069B1 (de) |
| DE (1) | DE69027562T2 (de) |
| DK (1) | DK0415456T3 (de) |
| ES (1) | ES2091212T3 (de) |
| GR (1) | GR3020715T3 (de) |
| HK (1) | HK1000600A1 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8817122U1 (de) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Xanthinderivate mit Adenosinantogenistischer Wirkung |
| US5290782A (en) * | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
| DE4019892A1 (de) * | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
| CA2061544A1 (en) * | 1991-02-25 | 1992-08-26 | Fumio Suzuki | Xanthine compounds |
| CA2082325A1 (en) * | 1991-11-08 | 1993-05-09 | Fumio Suzuki | Xanthine derivatives |
| JPH05294966A (ja) * | 1992-02-17 | 1993-11-09 | Kyowa Hakko Kogyo Co Ltd | キサンチン誘導体 |
| US5342841A (en) * | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
| US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
| TW252044B (de) * | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
| JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
| DE4238367A1 (de) * | 1992-11-13 | 1994-05-19 | Boehringer Ingelheim Kg | Diuretisches Mittel |
| WO1994016702A1 (fr) * | 1993-01-26 | 1994-08-04 | Kyowa Hakko Kogyo Co., Ltd. | Medicament contre l'elimination irreguliere des matieres fecales |
| US5395836A (en) * | 1993-04-07 | 1995-03-07 | Kyowa Hakko Kogyo Co., Ltd. | 8-tricycloalkyl xanthine derivatives |
| US5446046A (en) * | 1993-10-28 | 1995-08-29 | University Of Florida Research Foundation | A1 adenosine receptor agonists and antagonists as diuretics |
| US5736528A (en) * | 1993-10-28 | 1998-04-07 | University Of Florida Research Foundation, Inc. | N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
| WO1995031460A1 (en) * | 1994-05-17 | 1995-11-23 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing xanthine derivative |
| JP2001523213A (ja) | 1994-12-13 | 2001-11-20 | ユーロ−セルティーク，エス．エイ． | 三置換チオキサンチン類 |
| US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
| DE69531506T2 (de) * | 1994-12-13 | 2004-06-24 | Euroceltique S.A. | Arylthioxanthine |
| ES2199289T3 (es) * | 1995-07-26 | 2004-02-16 | Kyowa Hakko Kogyo Co., Ltd. | Dispersion solida de derivados de xantina. |
| US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
| US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
| AU7675498A (en) * | 1997-06-16 | 1999-01-04 | Kyowa Hakko Kogyo Co. Ltd. | Preventive and remedy for drug-induced nephropathy |
| DE19816857A1 (de) * | 1998-04-16 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP0970696A1 (de) * | 1998-05-05 | 2000-01-12 | Kyowa Hakko Kogyo Co., Ltd. | Zusammensetzung von Schleifendiuretika und Adenosin A1 Rezeptor Antagonisten |
| DE69933671T2 (de) * | 1998-06-01 | 2007-02-01 | Astellas Pharma Inc. | Adenosin a1 antagonisten gegen männliche sterilität |
| US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
| CA2390590C (en) | 1999-11-12 | 2010-03-16 | Biogen, Inc. | Adenosine receptor antagonists and methods of making and using the same |
| EP2305684A1 (de) | 1999-11-12 | 2011-04-06 | Biogen Idec MA Inc. | Polycycloalkylpurine als Adenosinrezeptorantagonisten |
| IL152023A0 (en) | 2000-04-26 | 2003-04-10 | Eisai Co Ltd | Compounds having adenosine a2 receptor antagonism and pharmaceutical compositions containing the same |
| YU42903A (sh) | 2000-12-01 | 2006-05-25 | Biogen Inc. | Kondenzovani derivati purina kao antagonisti a1 receptora adenozina |
| TWI301834B (en) | 2001-10-22 | 2008-10-11 | Eisai R&D Man Co Ltd | Pyrimidone compound and pharmaceutical composition including the same |
| UA84404C2 (ru) * | 2002-06-12 | 2008-10-27 | Байоджен Айдек Ма Инк. | Способ лечения ишемического реперфузионного повреждения с помощью антагонистов рецептора аденозина |
| US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
| AU2003249604B2 (en) * | 2003-05-06 | 2011-06-30 | Gilead Sciences, Inc. | A2B adenosine receptor antagonists |
| DK1658291T3 (da) * | 2003-08-25 | 2013-10-28 | Dogwood Pharmaceuticals Inc | Substituerede 8-heteroaryl xanthiner |
| EP1961422A1 (de) | 2005-12-14 | 2008-08-27 | Kyowa Hakko Kogyo Co., Ltd. | Einfach absorbiertes orales präparat mit einem xanthin-derivat |
| GB0708258D0 (en) * | 2007-04-27 | 2007-06-06 | Katholleke Universiteit Leuven | New anti-viral nulceoside analogs |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1245969B (de) * | 1967-08-03 | VEB Arzneimittelwerk Dresden, Radebeul | Verfahren zur Herstellung von Xanthinderivaten | |
| GB1201997A (en) * | 1967-08-04 | 1970-08-12 | Yissum Res Dev Co | New substituted purines and purine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US4783530A (en) * | 1986-11-13 | 1988-11-08 | Marion Laboratories, Inc. | 8-arylxanthines |
| DE8817122U1 (de) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Xanthinderivate mit Adenosinantogenistischer Wirkung |
-
1990
- 1990-08-30 JP JP22894190A patent/JPH06102662B2/ja not_active Expired - Lifetime
- 1990-08-31 DK DK90116791.6T patent/DK0415456T3/da active
- 1990-08-31 ES ES90116791T patent/ES2091212T3/es not_active Expired - Lifetime
- 1990-08-31 DE DE69027562T patent/DE69027562T2/de not_active Expired - Lifetime
- 1990-08-31 EP EP90116791A patent/EP0415456B1/de not_active Expired - Lifetime
- 1990-08-31 CA CA002024381A patent/CA2024381C/en not_active Expired - Fee Related
- 1990-08-31 AT AT90116791T patent/ATE139778T1/de not_active IP Right Cessation
-
1996
- 1996-08-02 GR GR960402079T patent/GR3020715T3/el unknown
-
1997
- 1997-05-12 BR BR1100762-1A patent/BR1100762A/pt active IP Right Grant
- 1997-11-19 HK HK97102197A patent/HK1000600A1/en not_active IP Right Cessation
-
1998
- 1998-09-11 CY CY9802069A patent/CY2069B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2024381A1 (en) | 1991-03-02 |
| DE69027562D1 (de) | 1996-08-01 |
| EP0415456A2 (de) | 1991-03-06 |
| CA2024381C (en) | 1997-01-07 |
| DK0415456T3 (da) | 1996-07-29 |
| ES2091212T3 (es) | 1996-11-01 |
| BR1100762A (pt) | 2000-03-14 |
| JPH03173889A (ja) | 1991-07-29 |
| EP0415456B1 (de) | 1996-06-26 |
| DE69027562T2 (de) | 1997-02-20 |
| HK1000600A1 (en) | 1998-04-09 |
| EP0415456A3 (en) | 1991-05-29 |
| JPH06102662B2 (ja) | 1994-12-14 |
| CY2069B1 (en) | 1998-09-11 |
| GR3020715T3 (en) | 1996-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69027562D1 (de) | Xanthinverbindungen | |
| CA2124680A1 (en) | Piperazine derivatives as 5-ht1a antagonists | |
| DK0386675T3 (da) | Xanthinderivater | |
| NO302755B1 (no) | Morfinan-derivater | |
| EP0031567A3 (de) | Tetrapeptidsemicarbazid-Derivate und deren Herstellung und Verwendung | |
| FR2593504B1 (fr) | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques | |
| DE3864707D1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
| ATE71944T1 (de) | Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| ES2003086A6 (es) | Procedimiento de obtencion de tienoquinolicinsulfonamidas | |
| DE68900990D1 (en) | Thioformamid-derivate. | |
| EP0347880A3 (de) | Imidazo[2,1-b]benzothiazol-Verbindungen und diese enthaltende Antiulkus-Zubereitungen | |
| FI883507A0 (fi) | Naftotiazepinderivat och deras framstaellning. | |
| ES556048A0 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
| ATE93524T1 (de) | Mitomycinanaloge, verfahren zu ihrer herstellung und pharmazeutische zubereitungen. | |
| AU4370489A (en) | The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents | |
| PH25608A (en) | 3-amino-tetrahydro-isoquinoline | |
| MX9701841A (es) | Derivados aminoheterociclicos como agentes antitromboticos o anticoagulantes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEFA | Change of the company name | ||
| EELA | Cancelled due to lapse of time |